	Investigational IL-17A antagonist in the treatment of psoriatic arthritis - a review. Expert Opin Investig Drugs Osunbor O, Nkeck JR, Adebajo AO. PMID: 42524831 [PubMed - as supplied by publisher]
	Erythrodermic psoriasis with early diagnostic uncertainty requiring multidisciplinary rheumatological management: A case report. Med Int (Lond) Danagara SR, Selvarajan T, Kannekanti L, Qamar A, Flowers A, Umer S. PMID: 42523983 [PubMed - as supplied by publisher]
	Diagnostic delay in the early phase of psoriatic arthritis is independently associated with adverse pain-related cognitive responses: a multicentre cross-sectional study. Front Immunol Capparelli E, Iacovantuono M, Tasso M, Del Vescovo S, Monosi B, Conigliaro P, Faggioli P, Iannone F, Lopalco G, Chimenti MS. PMID: 42523834 [PubMed - as supplied by publisher]
	Investigational interleukin 17A antagonists in the treatment of psoriatic arthritis. Expert Opin Investig Drugs Osunbor O, Nkeck JR, Adebajo AO. PMID: 42522956 [PubMed - as supplied by publisher]
	Effectiveness of bimekizumab according to previous biologic exposure in patients with plaque psoriasis: a multicenter real-world study. J Dermatolog Treat Trovato E, Di Cesare A, Panduri S, Pescitelli L, Ricceri F, Lo Conte S, Brandini L, Cuccia A, Romanelli M, Rubegni P, Prignano F. PMID: 42522774 [PubMed - as supplied by publisher]
	Microbiome dysbiosis in psoriatic skin among Asian populations: Insights from a systematic review and meta-analysis. Dermatol Online J Khan S, Hussain D, Ahmad H, Ahmed S. PMID: 42522515 [PubMed - as supplied by publisher]
	Self-reported factors influencing adherence to oral psoriasis treatment. Dermatol Online J Shaffer BR, Lovell KK, Greenzaid JD, Zaino M, Subramanian V, Sirdeshmukh D, Wiegandt N, Richardson I, Feldman SR. PMID: 42522509 [PubMed - as supplied by publisher]
	Extrapolating the speed of psoriasis clearance: Head-to-head agents in clinical trials. Dermatol Online J Pfau C, Lovell KK, Ozbeki H, Feldman SR. PMID: 42522487 [PubMed - as supplied by publisher]
	The efficacy and safety of interleukin-17 and interleukin-23 inhibitors in psoriatic arthritis across multiple disease domains. Dermatol Online J Zakria D, Shah M, Rosenberg A, Burshtein J, DeBusk L, Altman DA, Armstrong AW, Gottlieb AB, Han G, Khattri S, Shaigany S, Weinberg JM, Lebwohl M. PMID: 42522480 [PubMed - as supplied by publisher]
	Effectiveness and safety of switching biologics after secukinumab treatment failure in moderate-to-severe plaque psoriasis: a retrospective cohort study. Front Med (Lausanne) Zhang Z, Zhang B, Wen Y, Hu Q, Jiang W, Zhuo J, Luo G, Wang Y. PMID: 42519797 [PubMed - as supplied by publisher]
	Multi-omics Mendelian randomization identified adaptive immune response-related drug targets in psoriatic arthritis. Naunyn Schmiedebergs Arch Pharmacol Fan Z, Dong Q, Ding L, Zhang L, Yun X, Guo H. PMID: 42517881 [PubMed - as supplied by publisher]
	A randomized phase 2 trial of socrodeucitinib in moderate-to-severe plaque psoriasis. J Eur Acad Dermatol Venereol Han L, Geng S, Ding Y, Zhang S, Wang X, Hu F, Li J, Ci C, Hu Y, Chen R, Zhang J, Zhou X, Chen A, Zhang C, Lei T, Feng Y, Wang Y, Meng Z, Zhou Y, Ji M, Liu W, Wu Y, Chen Q, Wang S, Xu J. PMID: 42517728 [PubMed - as supplied by publisher]
	Image Processing for Diagnosing Psoriasis: A Machine Learning Approach to Classify Skin Lesions into Psoriasis Subtypes. Med J Islam Repub Iran Masoorian H, Gholamzadeh M, Firooz A, Safdari R. PMID: 42516629 [PubMed - as supplied by publisher]
	Exploring Rare and Atypical Forms of Psoriasis: A Narrative Review. J Clin Med Bardazzi F, Benedetto G, Clarizio G, Sacchelli L, Natale A, Chessa MA, Neri I, La Placa M, Balestri R. PMID: 42513452 [PubMed - in process]
	Treatment Switching and Drug Survival of Biologic Therapies in Psoriasis: A Real-World Italian Study Across Biologic Classes. J Clin Med Calabria S, Gisondi P, Talamonti M, Mantovani LG, Veronesi C, Degli Esposti L. PMID: 42513422 [PubMed - in process]
	Palmoplantar pustulosis is associated with greater burden and impaired quality of life compared to psoriasis only: findings from a cross-sectional study within the Danish Skin Cohort. J Am Acad Dermatol Stave SDW, Nymand LK, Thein D, Jensen MB, Thomsen SF, Thyssen JP, Egeberg A, Alinaghi F. PMID: 42508649 [PubMed - as supplied by publisher]
	Real-World Effectiveness and Safety of Ixekizumab in Moderate-to-Severe Plaque Psoriasis in the Indian Population: A Pilot Study. Indian Dermatol Online J Singh T, Srivastava S, Venugopal R, Agarwal R, Ranjan E, Gupta P. PMID: 42507504 [PubMed - as supplied by publisher]
	Novel insights into the role of microRNAs in atopic dermatitis and psoriasis: diagnostic and therapeutic aspects. Eur J Dermatol Yang J, Wang G, Zhang Y, Zheng R, Ren Y, Liu X, Shen Y, Yang M, Ou Y, Wang F, Zhang Y, Li N. PMID: 42507399 [PubMed - indexed for MEDLINE]
	Anthralin-From Psoriasis Drug to Power Adjuvant. Vaccines (Basel) Michael C, Bros M, Radsak MP, Schild H, Grabbe S. PMID: 42506667 [PubMed]
	The Use of High-Frequency Skin Ultrasound in the Evaluation of Psoriatic Plaques-A Pilot Comparative Study Between Conventional and Biological Therapy. J Imaging Ghilencea AF, Costache DO, C, Moga M, Costache RS. PMID: 42506164 [PubMed]

Articles 1 - 20 / 28293

Page 1 of 1415



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy